These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9645031)

  • 1. [Erythropoietic protoporphyria].
    Kondo M; Yano Y
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):155-7. PubMed ID: 9645031
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythropoietic protoporphyria].
    Miura T
    Nihon Rinsho; 1995 Jun; 53(6):1438-42. PubMed ID: 7616660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietic protoporphyria: identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies.
    Frank J; Nelson J; Wang X; Yang L; Ahmad W; Lam H; Jugert FK; Kalka K; Poh-Fitzpatrick MB; Goerz G; Merk HF; Christiano AM
    J Investig Med; 1999 Jul; 47(6):278-84. PubMed ID: 10431482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paralytic ileus and liver failure--an unusual presentation of advanced erythropoietic protoporphyria.
    Negrini S; Zoppoli G; Setti M; Cappellini MD; Indiveri F
    Dig Dis Sci; 2009 Feb; 54(2):411-5. PubMed ID: 19009347
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral cholestyramine is not an effective treatment for uncomplicated erythropoietic protoporphyria.
    Tewari A; Marsden J; Naik H; Benton EC; Sarkany R
    J Am Acad Dermatol; 2012 Dec; 67(6):1383-4. PubMed ID: 23158617
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.
    Yoo DJ; Lee HC; Yu E; Jin YJ; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ
    Korean J Hepatol; 2010 Mar; 16(1):83-8. PubMed ID: 20375647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy.
    Pawliuk R; Bachelot T; Wise RJ; Mathews-Roth MM; Leboulch P
    Nat Med; 1999 Jul; 5(7):768-73. PubMed ID: 10395321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical quiz.
    Gopalareddy V; Molle-Rios Z; Garola RE; Tung J
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):139-40. PubMed ID: 16819393
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations.
    Poh-Fitzpatrick MB; Wang X; Anderson KE; Bloomer JR; Bolwell B; Lichtin AE
    J Am Acad Dermatol; 2002 Jun; 46(6):861-6. PubMed ID: 12063482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer aspects on the treatment of erythropoietic protoporphyria.
    Sandberg S
    Photodermatol; 1985 Feb; 2(1):1-2. PubMed ID: 3982990
    [No Abstract]   [Full Text] [Related]  

  • 11. Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria.
    Childs S; Weinstein BM; Mohideen MA; Donohue S; Bonkovsky H; Fishman MC
    Curr Biol; 2000 Aug; 10(16):1001-4. PubMed ID: 10985389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed onset of cutaneous symptoms in erythropoietic protoporphyria.
    Varma S; Haworth A; Keefe M; Anstey AV
    Br J Dermatol; 2000 Jul; 143(1):221-3. PubMed ID: 10886182
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular characterization of a ferrochelatase gene defect causing anomalous RNA splicing in erythropoietic protoporphyria.
    Sarkany RP; Whitcombe DM; Cox TM
    J Invest Dermatol; 1994 Apr; 102(4):481-4. PubMed ID: 8151124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human erythropoietic protoporphyria: identification of a mutation at the splice donor site of intron 7 causing exon 7 skipping of the ferrochelatase gene.
    Nakahashi Y; Miyazaki H; Kadota Y; Naitoh Y; Inoue K; Yamamoto M; Hayashi N; Taketani S
    Hum Mol Genet; 1993 Jul; 2(7):1069-70. PubMed ID: 8364548
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver failure in erythropoietic protoporphyria.
    Sarkany RP; Cox TM
    J Am Acad Dermatol; 1996 Mar; 34(3):540-1. PubMed ID: 8609281
    [No Abstract]   [Full Text] [Related]  

  • 16. Picture of the month. Erythropoietic protoporphyria.
    Rector JT; DeLoach-Banta LJ; Barrett TL; Tunnessen WW
    Am J Dis Child; 1993 Jan; 147(1):73-4. PubMed ID: 8418605
    [No Abstract]   [Full Text] [Related]  

  • 17. Picture of the month. Erythropoietic protoporphyria.
    McMahon P; Yan A
    Arch Pediatr Adolesc Med; 2008 Jul; 162(7):689-90. PubMed ID: 18606941
    [No Abstract]   [Full Text] [Related]  

  • 18. Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria.
    Eichbaum QG; Dzik WH; Chung RT; Szczepiorkowski ZM
    Transfusion; 2005 Feb; 45(2):208-13. PubMed ID: 15660829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR; Wang Y; Singhal A; Risheg H
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promising new strategy for monitoring erythropoietic protoporphyria therapy.
    McGuire VA
    Br J Dermatol; 2016 Dec; 175(6):1144-1145. PubMed ID: 27996121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.